NDC 70842-101 – Baxdela
Delafloxacin Meglumine 450 mg/1 · Tablet · Oral
Product NDC70842-101
Product details
- Brand name
- Baxdela
- Generic name
- Delafloxacin meglumine
- Labeler
- Melinta Therapeutics, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA208610
- Marketed since
- June 19, 2017
- Listing expires
- December 31, 2026
- Pharmacologic class
- Fluoroquinolone Antibacterial
Active ingredients
- Delafloxacin Meglumine 450 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 70842-101-01 | 1 BOTTLE in 1 CARTON (70842-101-01) / 20 TABLET in 1 BOTTLE | Jun 19, 2017 |
| 70842-101-02 | 2 BLISTER PACK in 1 CARTON (70842-101-02) / 10 TABLET in 1 BLISTER PACK (70842-101-03) | Jun 19, 2017 |
| 70842-101-05 sample | 1 BLISTER PACK in 1 CARTON (70842-101-05) / 2 TABLET in 1 BLISTER PACK | May 9, 2018 |
Other Baxdela products
- 70842-102 Delafloxacin Meglumine 300 mg/10.5mL · Injection, Powder, Lyophilized, For Solution · Melinta Therapeutics, LLC